Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors.
Nat Commun. 2018 Nov 7;9(1):4655. doi: 10.1038/s41467-018-07078-0.
Nat Commun. 2018.
PMID: 30405134
Free PMC article.